Anurag S. Rathore is a professor in the Department of Chemical Engineering at the Indian Institute of Technology Delhi and a member of BioPharm International's Editorial Advisory Board, Tel. +91.9650770650, asrathore@biotechcmz.com.

Anurag S. Rathore

Articles

This article presents some key differences between the US and European regulation of biosimilars, including naming conventions and pharmacovigilance of biosimilars, and the impact of biosimilars on commercialization and affordability of biotherapeutics.

Challenges with Successful Commercialization of Biosimilars

A major advantage of SPR-based analysis is its ability to estimate the association and dissociation rate constants, an advancement over the traditional steady-state analysis of biomolecules.

Real-Time Characterization of Biotherapeutics and Comparability of Biosimilars

Kinetic models can be used to study aggregation and fragmentation to help ensure stability.

Modeling the Degradation of mAb Therapeutics

Transcriptomics plays a role in influencing the production of recombinant therapeutics in microbial and mammalian hosts.

Author | Anurag S. Rathore